Gerald (Gerry) Haines III, Chief Financial Officer, Metabolon

Gerald (Gerry) M. Haines II

Gerry drives the company’s financial vision and strategy along with investor relations, while also ensuring strong financial processes and reporting to support overall company strategy and effective operational decision-making.

About Gerry Haines, Chief Financial Officer

Gerry has built a career helping propel companies through sustained periods of rapid, scalable growth, highlighted by multiple public and private equity transactions accessing growth capital to support those initiatives. Before Metabolon, Gerry was Executive Vice President and CFO of Impulse Dynamics, a leading medical device company, where he led multiple corporate functions supporting the company’s financial and business transformation through strategy development, operational execution, and multiple successful financings. During his time at Impulse Dynamics, the company shifted rapidly from late-stage technology development to a premium-valued commercial entity. Before Impulse, Gerry held senior executive leadership roles at multiple public companies, including Mercury Systems (Nasdaq: MRCY), which grew five-fold during his time as CFO, and Verenium Corporation (Nasdaq: VRNM), where he negotiated the implementation and subsequent sale of a major joint venture with BP, with the company later being acquired by BASF. Gerry earned a Bachelor of Science in Business Administration from Boston University Questrom School of Business and a Juris Doctor from Cornell Law School.

See how Metabolon can advance your path to preclinical and clinical insights